Clinical Trials Logo

Clinical Trial Summary

This study is designed to investigate the response of unilateral upper extremity (arm) lymphedema, during pharmacologic treatment of lymphedema with oral placebo and oral acebilustat. Participants will receive "study drug" (Acebilustat or placebo), for 9 months. For 3 of these months, the participant will receive placebo; for 6 of these months, the participant will receive active ingredient, acebilustat. The study is blinded which means that the participant will not be told which study pill they are taking.


Clinical Trial Description

To enter this study, participants will have to meet requirements that will be evaluated during screening, Visit 1. If eligible, and if they choose to continue, Visit 2, treatment start, will take place 2-7 days later. Study visits are every (approximately) 90 days. Physical exam, including limb measurements and skin measurements (with tape measure and dermal ultrasound) are performed. Phlebotomy for research samples and clinical labs will be performed at study start and end of study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05203835
Study type Interventional
Source Stanford University
Contact Leslie Roche, RN
Phone 650-725-7571
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date May 15, 2022
Completion date August 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04858230 - LymphoPilot Test for Arm Lymphedema N/A
Recruiting NCT03492476 - Circaid® Compression Sleeve Versus Short-stretching Bandage in Upper Limb Lymphatic Edema N/A
Completed NCT03676127 - Diagnostic Accuracy of Dermal Thickness in Lymphedema
Recruiting NCT04570722 - Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study) N/A
Recruiting NCT03210311 - Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema N/A
Not yet recruiting NCT04435639 - Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema N/A
Active, not recruiting NCT02691624 - Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After Operation
Not yet recruiting NCT04139291 - Ultrasonographic Evaluation of Changes After Complex Decongestive Therapy N/A
Recruiting NCT04138667 - Responsiveness of Outcome Scales in Breast Cancer Related Lymphedema N/A
Recruiting NCT04296929 - The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema. N/A
Recruiting NCT05278871 - Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors N/A
Recruiting NCT04908254 - A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema N/A
Not yet recruiting NCT04881604 - Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema N/A
Not yet recruiting NCT04934098 - Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema N/A
Recruiting NCT04203069 - Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase N/A
Withdrawn NCT04246034 - Microvascular Breast Reconstruction With Lymph Node Transfer N/A
Completed NCT04213001 - Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema N/A
Recruiting NCT04690439 - Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema N/A
Recruiting NCT05142800 - Screening For BCRL In Targeted Therapy For Breast Cancer
Recruiting NCT04821609 - Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema N/A